查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1871304

尿动力学设备及耗材市场机会、成长驱动因素、产业趋势分析及预测（2025-2034年）

Urodynamic Equipment and Consumables Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年全球尿力学设备及耗材市场价值为 3.667 亿美元，预计到 2034 年将以 6.9% 的复合年增长率增长至 7.045 亿美元。

尿动力学设备及耗材市场 - IMG1

尿动力学设备技术的快速发展、泌尿系统疾病盛行率的上升、人们对早期诊断意识的增强以及门诊和流动医疗中心的兴起，是推动市场成长的主要因素。尿动力学设备及其耗材是评估下泌尿道功能的关键工具，用于测量膀胱压力、尿流率和括约肌活动，从而识别泌尿系统疾病的根本原因。导管、感测器和管路等耗材是进行这些诊断测试的必要条件。无线导管、便携式尿路动力学设备、多通道压力系统和软体解决方案等创新技术提高了测试的准确性、易用性和患者舒适度。此外，微创技术、无线技术、数位医疗的整合、居家检测以及新兴市场应用的日益普及也推动了市场的发展。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 3.667亿美元
预测值 7.045亿美元
复合年增长率 6.9%

2024年，设备类市占率将达到66.9%，这主要得益于泌尿系统疾病盛行率的上升以及医院和专科诊所对先进诊断工具的日益普及。老年族群的需求尤其强劲，因为他们更容易出现泌尿功能障碍，因此准确的尿动力学评估对于正确的治疗至关重要。

2024年，医院业务占市场份额的52.9%，预计在2025年至2034年期间将达到3.649亿美元。泌尿科的扩张，加上全面的诊断服务，吸引了更多患者，并提高了设备和耗材的使用率。

2024年，美国尿动力学设备及耗材市场规模预估为1.565亿美元。尿失禁、膀胱过动症和摄护腺疾病的高发生率，以及人们对精准诊断的广泛认知，正促使医院和诊所采用先进的诊断系统。医疗保险（包括联邦医疗保险和医疗补助）的覆盖范围降低了患者的医疗费用，鼓励患者进行频繁检查，并进一步激励医疗机构投资于现代化的诊断设备和耗材。

全球尿电动力学设备及耗材市场的主要参与者包括 Medica、Advin、HC Italia、Ashlar Medical、Santron Meditronic、Albyn Medical (CREO MEDICAL)、Neomedix Systems、Digitimer、CooperSurgical、LABORIE、Tic Medizintechnik、The Prometheus Group、CoperSurgical、LABORIE、Tic Medizintechnik、The Prometheus Group、CoperSurgical、LABORIE、Tic Medizintechnik、The Prometheus Group、C​​nectron 或SRS Medicaln ​​SRSc​​D 75% ARS尿动力学设备及耗材市场的企业正采取多种策略来巩固其市场地位。他们专注于开发便携式、无线和无导管设备，以提高患者舒适度并提升工作流程效率。持续的研发投入使企业能够推出创新的软体整合解决方案，用于即时监控和远端诊断。与医院、门诊中心和远距医疗服务提供者建立策略合作伙伴关係，有助于扩大分销管道和市场渗透率。遵守监管标准确保了产品的安全性和可靠性，从而赢得了医疗服务提供者的信任。

目录

第一章：方法论与范围

第二章：执行概要

第三章：行业洞察

  • 产业生态系分析
  • 产业影响因素
    • 成长驱动因素
      • 下泌尿道症状（LUTS）和泌尿系统疾病的盛行率增加
      • 人们对尿失禁治疗的认识不断提高，加上政府采取的促进性倡议，使得尿失禁的治疗日益受到重视。
      • 尿动力学设备的技术进步
    • 产业陷阱与挑战
      • 设备成本高和监管政策严格
    • 市场机会
      • 对便携式和无线尿路动力学设备的需求日益增长
      • 随着医疗保健服务的改善，新兴市场将实现扩张。
  • 成长潜力分析
  • 报销方案
  • 监管环境
    • 北美洲
    • 欧洲
    • 亚太地区
  • 技术格局
    • 当前技术趋势
    • 新兴技术
  • 消费者洞察
  • 价值链分析
  • 未来市场趋势
  • 波特的分析
  • PESTEL 分析
  • 差距分析

第四章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
    • 全球的
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
  • 竞争定位矩阵
  • 主要市场参与者的竞争分析
  • 关键进展
    • 併购
    • 合作伙伴关係与合作
    • 新产品发布
    • 扩张计划

第五章：市场估算与预测：依产品类型划分，2021-2034年

  • 主要趋势
  • 装置
    • 尿动力学系统
      • 标准尿动力学系统
      • 视讯尿动力学系统
    • 尿流率测定设备
    • 膀胱测压器
    • 肌电图仪
  • 消耗品
    • 尿动力学导管
    • 感测器组
    • 尿动力泵
    • 其他消耗品

第六章：市场估算与预测：依最终用途划分，2021-2034年

  • 主要趋势
  • 医院
  • 泌尿科诊所
  • 门诊手术中心
  • 其他最终用途

第七章：市场估计与预测：依地区划分，2021-2034年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第八章：公司简介

  • Advin
  • Albyn Medical (CREO MEDICAL)
  • Ashlar Medical
  • COOK MEDICAL
  • CooperSurgical
  • Digitimer
  • HC Italia
  • Laborie
  • Medica
  • MEDKONSULT medical technology
  • Neomedix Systems
  • Santron Meditronic
  • SRS Medical
  • The Prometheus Group
  • Tic Medizintechnik
简介目录
Product Code: 3883

The Global Urodynamic Equipment and Consumables Market was valued at USD 366.7 million in 2024 and is estimated to grow at a CAGR of 6.9% to reach USD 704.5 million by 2034.

Urodynamic Equipment and Consumables Market - IMG1

The growth is driven by rapid technological advancements in urodynamic devices, the increasing prevalence of urological disorders, growing awareness about early diagnosis, and the rise of outpatient and ambulatory care centers. Urodynamic equipment and consumables are critical tools used to evaluate the function of the lower urinary tract, measuring bladder pressure, urine flow, and sphincter activity to identify the underlying causes of urinary disorders. Consumables, such as catheters, sensors, and tubing, are essential for performing these diagnostic tests. Innovations, including wireless catheters, portable urodynamic devices, multi-channel pressure systems, and software-based solutions, improve accuracy, ease of use, and patient comfort. The market is also being fueled by the shift toward minimally invasive, wireless technologies, digital health integration, home-based testing, and growing adoption in emerging markets.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$366.7 Million
Forecast Value$704.5 Million
CAGR6.9%

The equipment segment held a 66.9% share in 2024, driven by the rising prevalence of urinary disorders and increased use of advanced diagnostic tools in hospitals and specialized clinics. Demand is particularly strong among the elderly, who are more prone to urinary dysfunction, making accurate urodynamic assessments essential for proper treatment.

The hospitals segment held a 52.9% share in 2024 and is expected to reach USD 364.9 million during 2025-2034. Expanding urology departments, coupled with comprehensive diagnostic offerings, attract more patients and increase the adoption of both equipment and consumables.

U.S. Urodynamic Equipment and Consumables Market was valued at USD 156.5 million in 2024. High incidences of urinary incontinence, overactive bladder, and prostate disorders, combined with widespread awareness of accurate diagnostics, are prompting hospitals and clinics to adopt advanced systems. Insurance coverage, including support from Medicare and Medicaid, reduces patient costs, encouraging frequent testing and further motivating healthcare providers to invest in modern diagnostic equipment and consumables.

Key players in the Global Urodynamic Equipment and Consumables Market include Medica, Advin, HC Italia, Ashlar Medical, Santron Meditronic, Albyn Medical (CREO MEDICAL), Neomedix Systems, Digitimer, CooperSurgical, LABORIE, Tic Medizintechnik, The Prometheus Group, COOK MEDICAL, SRS Medical, and MEDKONSULT medical technology. Companies in the Urodynamic Equipment and Consumables Market are adopting multiple strategies to strengthen their market position. They are focusing on the development of portable, wireless, and catheter-free devices that enhance patient comfort and improve workflow efficiency. Continuous investment in R&D allows firms to introduce innovative, software-integrated solutions for real-time monitoring and remote diagnostics. Strategic partnerships with hospitals, outpatient centers, and telemedicine providers expand distribution and market penetration. Compliance with regulatory standards ensures product safety and reliability, building trust among healthcare providers.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Product type trends
    • 2.2.3 End Use trends
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increase in prevalence of lower urinary tract symptoms (LUTS) and urological disorders
      • 3.2.1.2 Growing awareness coupled with facilitative government initiatives for incontinence treatment
      • 3.2.1.3 Technological advancements in urodynamic equipment
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of equipment and strict regulatory policies
    • 3.2.3 Market opportunities
      • 3.2.3.1 Growing demand for portable and wireless urodynamic devices
      • 3.2.3.2 Expansion in emerging markets with improving healthcare access
  • 3.3 Growth potential analysis
  • 3.4 Reimbursement scenario
  • 3.5 Regulatory landscape
    • 3.5.1 North America
    • 3.5.2 Europe
    • 3.5.3 Asia Pacific
  • 3.6 Technology landscape
    • 3.6.1 Current technological trends
    • 3.6.2 Emerging technologies
  • 3.7 Consumer insights
  • 3.8 Value chain analysis
  • 3.9 Future market trends
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis
  • 3.12 Gap analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
    • 4.3.1 Global
    • 4.3.2 North America
    • 4.3.3 Europe
    • 4.3.4 Asia Pacific
    • 4.3.5 LAMEA
  • 4.4 Competitive positioning matrix
  • 4.5 Competitive analysis of major market players
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Equipment
    • 5.2.1 Urodynamic system
      • 5.2.1.1 Standard urodynamic systems
      • 5.2.1.2 Video urodynamic systems
    • 5.2.2 Uroflowmetry equipment
    • 5.2.3 Cystometer
    • 5.2.4 Electromyographs
  • 5.3 Consumables
    • 5.3.1 Urodynamic catheters
    • 5.3.2 Transducer sets
    • 5.3.3 Urodynamic pumps
    • 5.3.4 Other consumables

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Hospitals
  • 6.3 Urology clinics
  • 6.4 Ambulatory surgical centers
  • 6.5 Other End use

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Netherlands
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
  • 7.6 Middle East and Africa
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE

Chapter 8 Company Profiles

  • 8.1 Advin
  • 8.2 Albyn Medical (CREO MEDICAL)
  • 8.3 Ashlar Medical
  • 8.4 COOK MEDICAL
  • 8.5 CooperSurgical
  • 8.6 Digitimer
  • 8.7 HC Italia
  • 8.8 Laborie
  • 8.9 Medica
  • 8.10 MEDKONSULT medical technology
  • 8.11 Neomedix Systems
  • 8.12 Santron Meditronic
  • 8.13 SRS Medical
  • 8.14 The Prometheus Group
  • 8.15 Tic Medizintechnik